Peregrine Asset Advisers’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-45,779
Closed -$530K 154
2013
Q2
$530K Buy
+45,779
New +$530K 0.55% 43